1 April 2020 News
Artificial intelligence (AI) drug discovery company Exscientia has expanded its ongoing anti-viral drugs partnership with the UK’s national synchrotron facility Diamond Light Source and University of Oxford across the Atlantic...
31 March 2020 Analysis
AI has revolutionised healthcare by drastically reducing the time it takes to develop and commercialise a drug. Allie Nawrat talks to IQVIA’s technology solutions practice leader Updesh Dosanjh about the...
25 March 2020 Analysis
The reality of climate change is hard to ignore. As one of the biggest polluters, and simultaneously the industry tasked with trying to tackle the global health outcomes of environmental...
3 February 2020 Analysis
How will life sciences and healthcare have advanced by 2030? The Pistoia Alliance has published a report suggesting possible answers to this question, thereby helping companies and organisations decide where...
12 December 2019
Spanish pharmaceutical firm Almirall has agreed with Iktos to leverage the latter’s generative modelling artificial intelligence (AI) technology to design novel drugs.
11 December 2019 News
Flagship Pioneering has launched a new company, Cellarity, to discover drugs based on insights from research of cellular behaviours.
10 December 2019
German pharmaceutical company Boehringer Ingelheim has partnered with UK-based drug technology firm Healx to identify approaches to treat rare neurological disorders.
5 December 2019
Novartis has collaborated with Amazon Web Services (AWS) to digitally transform the manufacturing, supply chain and delivery of its medicines using cloud services.
17 October 2019 News
UK-based company Healx has raised $56m in a Series B funding round for the development of rare disease treatments that are identified using artificial intelligence (AI) technology called Healnet.